Cabozantinib Elicits Significant Responses in RCC Patients with Brain Metastases
Physician's Weekly,
No increased toxicity observed in retrospective…
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma
Overview of attention for article published in JAMA Oncology, December 2021
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (98th percentile)
-
High Attention Score compared to outputs of the same age and source (87th percentile)
Mentioned by
- news
- 16 news outlets
- blogs
- 1 blog
- policy
- 1 policy source
- 125 X users
- 1 Redditor
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 43 Mendeley